Latest hematology News

PSA Levels Alone May Not Reflect Prostate Cancer Growth
700-million-year History Of Our Blood Cells
Unusual tumor cells may be overlooked factors in advanced breast cancer
NextGenNK At ASH 2025
A Life Rewritten: KFSHRC Treats Rare Disease After 22 Years of Specialized Care
Baylor researchers receive CPRIT funding for cancer research
Allen and Kanwal elected to the American Association of Physicians
New research points out a promising strategy for treating metastatic medulloblastoma
Cracking the code of lethal antibodies in a new blood-clotting disorder
A battle of rafts: How molecular dynamics in CAR T cells explain their cancer-killing behavior
ZIC1 gene drives distinct medulloblastoma types in different ways
KFSHRC Inaugurates MENA’s Most Advanced Hematology Diagnostics Laboratory
“CAR T-cell Therapy Is Here To Stay”
DoD grant funds innovative approach to fighting kidney cancer
CAR T cells armed with IL-15 show promise in treating solid cancers
Swedish Cancer Society grants SEK 23 million to MedH researchers
New Tool Quantifies Cancer’s Ability To Shape-shift
Baylor College of Medicine receives more than $17 million from CPRIT
Blood test may guide use of multiple myeloma immunotherapy
Study points at novel approach to treat Group 3 medulloblastoma
Femke Hormann awarded prestigious Junior Research Grant from European Hematology Association
Specialist centre at KI delivers expertise in radiation emergency medicine
Immune cells lost in translation: Breakthrough into body’s response to blood cancer
CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I trial
Collaboration With University Of Kragujevac In Serbia
Long-term ALPHA Phase III trial data showed danicopan as add-on to Ultomiris or Soliris sustained clinical improvements in subset of patients with…
AstraZeneca advances scientific leadership in haematology at ASH 2023
New strategy attacks treatment-resistant lymphomas
Examining outcomes in children with Down syndrome and acute lymphoblastic leukemia
Dietary supplement modifies gut microbiome
Prescient to announce Phase 1b cancer trial results at world’s largest haematology conference
Technique shows how abnormal RNA splicing leads to disease
AZD0466 clinical data presented by AstraZeneca at international congress
Danicopan as add-on to Ultomiris or Soliris improved haemoglobin levels and maintained disease control in patients with PNH experiencing signs or symptoms…
BostonGene and Mater Research collaborate in new follicular lymphoma study
Clinical Genome Resource receives global recognition
AstraZeneca showcases strength of haematology portfolio and pipeline across multiple hard-to-treat conditions
HKUST Installs First Woman President Prof. Nancy Ip at 30th Congregation
Flow Cytometry Core Facility provides cell analysis expertise to scientists
CSL and Translational Sciences enter Agreement
Corrupt endothelial cells protect blood cancer cells from chemotherapy
Study sheds light on precancerous ‘clonal outgrowth’ in blood cells
University of Toronto grad Ben Ouyang wants to answer ‘questions that matter most to patients and their families’
Researchers identify Achilles’ heel in neuroblastoma
New research identifies more effective weapon against blood cancers
Mantle cell lymphoma treatment varies according to setting
AstraZeneca demonstrates pipeline and portfolio strength across malignant and rare haematological diseases
Immune therapy targets cells that cause leukemia relapse